Abbott Laboratories (ABT)

Current ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total current assets US$ in thousands 22,670,000 22,664,000 23,505,000 24,377,000 25,224,000 24,845,000 24,956,000 23,429,000 24,239,000 23,492,000 22,627,000 21,817,000 20,441,000 17,390,000 17,221,000 15,498,000 15,667,000 16,119,000 15,195,000 14,409,000
Total current liabilities US$ in thousands 13,841,000 13,042,000 14,350,000 14,530,000 15,489,000 13,365,000 12,392,000 12,647,000 13,105,000 12,867,000 12,614,000 12,462,000 11,907,000 10,257,000 10,959,000 10,808,000 10,863,000 10,491,000 9,062,000 9,113,000
Current ratio 1.64 1.74 1.64 1.68 1.63 1.86 2.01 1.85 1.85 1.83 1.79 1.75 1.72 1.70 1.57 1.43 1.44 1.54 1.68 1.58

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $22,670,000K ÷ $13,841,000K
= 1.64

The current ratio for Abbott Laboratories has shown some fluctuation over the past eight quarters. As of Q4 2023, the current ratio stands at 1.64, which indicates that the company has $1.64 in current assets to cover each dollar of current liabilities. This ratio has decreased from the previous quarter, Q3 2023, where it was 1.74.

Looking further back, the current ratio has displayed a general downward trend since Q2 2022, where it peaked at 2.01. This decline may suggest that the company's liquidity position has weakened over time, as it now has a lower ability to meet its short-term obligations with its current assets.

Although the current ratio has declined, it is essential to note that a current ratio above 1.0 still indicates that Abbott Laboratories has more current assets than current liabilities. However, the decreasing trend warrants further analysis to understand the underlying reasons and potential implications for the company's financial health and operational efficiency.


Peer comparison

Dec 31, 2023


See also:

Abbott Laboratories Current Ratio (Quarterly Data)